Byooviz
Ranibizumab-nuna · Harrow Eye, LLC
PRESCRIPTION ONLY (USA)Byooviz ingredients
| Active ingredient | Strength |
|---|---|
| Ranibizumab | 10 mg/mL |
What Byooviz is used for
Byooviz is a specialist medicine (vascular endothelial growth factor inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Byooviz
- Generic name
- Ranibizumab-nuna
- Made by
- Harrow Eye, LLC
- Forms
- Injection, Solution
- Given
- Intravitreal
- Drug class
- Vascular Endothelial Growth Factor Inhibitor
- FDA approval
- Biologic licence (BLA) BLA761202
- On the US market since
- 2022
Official information
- Byooviz prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Ranibizumab-nuna)
In India
- Ranibizumab: 2 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Byooviz?
Byooviz (Ranibizumab-nuna) is a specialist medicine made by Harrow Eye, LLC, approved by the US FDA.
What are the ingredients of Byooviz?
Byooviz contains Ranibizumab (10 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA